⭕Faye Yosun
liked
Finally, after patiently waiting for the main stock and warrants to fall to the additional purchase range, we welcome them again. $NUVATION BIO INC C/WTS 07/07/2027 (TO PUR COM) (NUVB.WS.US)$ 🔴 Finally waited for the simultaneous decline of the underlying stock and warrants, seizing the opportunity to increase holdings, and incrementally adding positions through pending orders.
🔆The company currently has 0.57 billion US dollars, burning less than $30 million on average per quarter. It is expected that the company's new drug commercialized products will be launched by the end of 2025. Although sales expenses will increase in the early stages of listing, they will also bring corresponding revenue and regional market licensing fees to the company. Once the market expectations are positive, the stock price will also enter a golden period, especially the market prospects in mainland China will be an important factor for explosive growth. At the same time, the company's other drugs in clinical stages are also worth looking forward to!
Pipeline - NUVATION BIO, INC.
Look Forward to Further Advancing Taletrectinib and Plan to Share Results From Global, Pivotal Trust-II Study by End of 2024
The stock warrant will expire in 2027. If everything goes smoothly, it may obtain returns significantly exceeding expectations.
Current data shows, $Nuvation Bio (NUVB.US)$ according to...
🔆The company currently has 0.57 billion US dollars, burning less than $30 million on average per quarter. It is expected that the company's new drug commercialized products will be launched by the end of 2025. Although sales expenses will increase in the early stages of listing, they will also bring corresponding revenue and regional market licensing fees to the company. Once the market expectations are positive, the stock price will also enter a golden period, especially the market prospects in mainland China will be an important factor for explosive growth. At the same time, the company's other drugs in clinical stages are also worth looking forward to!
Pipeline - NUVATION BIO, INC.
Look Forward to Further Advancing Taletrectinib and Plan to Share Results From Global, Pivotal Trust-II Study by End of 2024
The stock warrant will expire in 2027. If everything goes smoothly, it may obtain returns significantly exceeding expectations.
Current data shows, $Nuvation Bio (NUVB.US)$ according to...
Translated
+3
11
⭕Faye Yosun
voted
Hi, mooers!
Welcome back to Maple Market Challenge!
Like always, let's reveal the answer to last week's quiz: What is the reason behind Palantir and Dell joining the S&P 500 on September 23? The answer is "the rising momentum in AI".
96% mooers chose the correct answer! A big round of applause to those who got it right! Each of you will receive 20 points. Plus, we're giving 50 points to everyone who left a comment....
Welcome back to Maple Market Challenge!
Like always, let's reveal the answer to last week's quiz: What is the reason behind Palantir and Dell joining the S&P 500 on September 23? The answer is "the rising momentum in AI".
96% mooers chose the correct answer! A big round of applause to those who got it right! Each of you will receive 20 points. Plus, we're giving 50 points to everyone who left a comment....
38
25
Don't be discouraged, there are plenty of opportunities.
Translated
4
⭕Faye Yosun
commented on and voted
Hi, mooers!
Welcome back to Maple Market Challenge!
Like always, let's reveal the answer to last week's quiz: What event on September 19 could drive Faraday Future's growth? The answer is China-U.S. Automotive Bridge Strategy.
A big round of applause to those who got it right! Each of you will receive 20 points. Plus, we're giving 50 points to everyone who left a comment. Well done, everyone! A private message with...
Welcome back to Maple Market Challenge!
Like always, let's reveal the answer to last week's quiz: What event on September 19 could drive Faraday Future's growth? The answer is China-U.S. Automotive Bridge Strategy.
A big round of applause to those who got it right! Each of you will receive 20 points. Plus, we're giving 50 points to everyone who left a comment. Well done, everyone! A private message with...
34
34
⭕Faye Yosun
commented on and voted
Hi, mooers!
Welcome back to Maple Market Challenge!
Like always, let's reveal the answer to last week's quiz: At what price per share is Scotiabank acquiring the stake in KeyCorp? The answer is $17.17.
A big round of applause to those who got it right! Each of you will receive 20 points. Plus, we're giving 50 points to everyone who left a comment. Well done, everyone! A private message with...
Welcome back to Maple Market Challenge!
Like always, let's reveal the answer to last week's quiz: At what price per share is Scotiabank acquiring the stake in KeyCorp? The answer is $17.17.
A big round of applause to those who got it right! Each of you will receive 20 points. Plus, we're giving 50 points to everyone who left a comment. Well done, everyone! A private message with...
33
22
⭕Faye Yosun
commented on and voted
Hi, mooers!
Welcome back to Maple Market Challenge!
Like always, let's reveal the answer to last week's quiz: What impact did Elon Musk's endorsement of Donald Trump have on Tesla's stock price? The answer is 'surged more than 5%'.
A big round of applause to those who got it right! Each of you will receive 20 points. Plus, we're giving 50 points to everyone who left a comment. Well done, e...
Welcome back to Maple Market Challenge!
Like always, let's reveal the answer to last week's quiz: What impact did Elon Musk's endorsement of Donald Trump have on Tesla's stock price? The answer is 'surged more than 5%'.
A big round of applause to those who got it right! Each of you will receive 20 points. Plus, we're giving 50 points to everyone who left a comment. Well done, e...
32
19
⭕Faye Yosun
voted
Recent U.S. economic reports, yen carry trade issues, and global tensions have rocked the stock market. A disappointing July jobs report caused market instability, but a positive update on jobless claims sparked the S&P 500's largest rally in nearly two years. Now, the upcoming release of July's CPI is drawing attention, with potential to cause significant market reactions.
Investors should adjust their strategies based on economic indicators. Fo...
Investors should adjust their strategies based on economic indicators. Fo...
+2
30
6
⭕Faye Yosun
liked
$NewAmsterdam Pharma (NAMS.US)$ ⭕NewAmsterdam Pharma(NAMS)周一表示,对于家族性高胆固醇血症杂合子患者潜在降低胆固醇的药物obicetrapib的3期临床研究已达到主要终点,但是,股价却在消息发布后跌超8%,为此,找到相关本次临床相关信息以便进一步评估其下跌:
🔺obicetrapib是用于治疗低密度脂蛋白胆固醇(“LDL-C”)升高且有心血管疾病(“CVD”)风险的患者,这些患者现有疗法效果不够好或耐受性不佳
🔺本次临床试验的对象及其入选条件
Study Overview
Brief Summary
This study will be a placebo-controlled, double-blind, randomized, phase 3 study to Evaluate the Efficacy, Safety, and Tolerability of Obicetrapib in Participants with a History of Heterozygous Familial Hyper...
🔺obicetrapib是用于治疗低密度脂蛋白胆固醇(“LDL-C”)升高且有心血管疾病(“CVD”)风险的患者,这些患者现有疗法效果不够好或耐受性不佳
🔺本次临床试验的对象及其入选条件
Study Overview
Brief Summary
This study will be a placebo-controlled, double-blind, randomized, phase 3 study to Evaluate the Efficacy, Safety, and Tolerability of Obicetrapib in Participants with a History of Heterozygous Familial Hyper...
+2
10
⭕Faye Yosun
liked
$Apple (AAPL.US)$ is expected to release its Q2 FY 2024 earnings report on Thursday, May 2, after the market closes. So far this year, the tech giant has faltered by almost 12%, significantly lagging behind the $S&P 500 Index (.SPX.US)$ and its Mag 7 peers, except for $Tesla (TSLA.US)$. As analysts express apprehension regarding the company's challenges in China, ambiguity surrounding...
40
5
⭕Faye Yosun
commented on
Thank you moomoo for 3 months of Nasdaq Totalview! The detailed real time data updates are very useful informations to have!
Plan is to continue RSP into various funds and stocks
Plan is to continue RSP into various funds and stocks
7
9